| 金思思,王燕飞,杨文广,金林珍.薄氏腹针联合抗炎方封包治疗腰背肌筋膜炎临床观察[J].浙江中西医结合杂志,2025,35(4): |
| 薄氏腹针联合抗炎方封包治疗腰背肌筋膜炎临床观察 |
| Clinical observation on the treatment of lumbar and back myofascitis with Boshi abdominal acupuncture combined with kangyan fengbao prescription encapsulation |
| 投稿时间：2024-09-10 修订日期：2025-03-08 |
| DOI： |
| 中文关键词: 薄氏腹针 抗炎方 中药封包 腰背肌筋膜炎 疼痛评分 疼痛介质 炎症因子 |
| 英文关键词:Boshi abdominal acupuncture Kangyan fengbao prescription encapsulation Chinese medicine encapsulation Lumbar and back myofascitis Pain score Pain mediators Inflammatory factor |
| 基金项目:2023年温州市基础性科研项目(Y2023962) |
|
| 摘要点击次数: 267 |
| 全文下载次数: 2 |
| 中文摘要: |
| 目的：探讨薄氏腹针联合抗炎方热敷治疗腰背肌筋膜炎临床疗效。方法：选择于浙江省立同德医院就诊的腰背肌筋膜炎患者96例,采用简单化分组方法随机分为两组各48例,对照组给予抗炎方封包治疗,观察组在其基础上给予薄氏腹针针刺治疗。观察两组患者治疗前后的疼痛量表评分(简化McGill疼痛问卷量表、腰背部Dswestry功能障碍指数、罗兰-莫里斯功能障碍问卷表),血清疼痛介质(前列腺素E2、β-内啡肽、5-羟色胺),血清炎症因子(白细胞介素-1β、白细胞介素-6、P物质)、腰背功能情况(日本骨科协会评分)、中医证候评分及临床疗效。结果：治疗后两组疼痛量表评分、血清疼痛介质、炎症因子、日本骨科协会评分、中医证候评分及均较治疗前降低,且观察组低于对照组(P＜0.05)。治疗后观察组总有效率为93.75%显著高于对照组81.25%(P＜0.05)。结论：薄氏腹针联合抗炎方封包治疗腰背肌筋膜炎临床疗效显著。 |
| 英文摘要: |
| Objective: To investigate the clinical effect of Boshi abdominal acupuncture combined with kangyan fengbao prescription encapsulation in the treatment of lumbar and back myofasciitis. Methods: 96 patients with lumbar and back myofascitis were selected from Zhejiang Provincial Tongde Hospital. The control group was given kangyan fengbao prescription encapsulation treatment, and the observation group was given Boshi abdominal acupuncture treatment on the basis of it. Pain scale scores (simplified McGill Pain Questionnaire, low back Dswestry Disability Index, Loran-Morris Dysfunction Questionnaire), serum pain mediators (prostaglandin E2, beta-endorphin, 5-hydroxytryptamine) were observed before and after treatment in both groups. Serum inflammatory factors (interleukin-1β, interleukin-6, Substance P), lumbar and back function (Japanese Orthopaedic Association score), TCM syndrome score and clinical efficacy. Results: After treatment, the score of pain scale, serum pain mediators, inflammatory factors, Japanese Orthopaedic Association score and Chinese medicine syndrome score were all lower than before treatment,(P < 0.05). After treatment, the observation group total effective rate was 93.75% higher than that of control group 81.25% (P < 0.05). Conclusion: Boshi abdominal acupuncture combined with kangyan fengbao prescription encapsulation has significant clinical effect on lumbar and back myofasciitis. |
| 查看全文 查看/发表评论 下载PDF阅读器 |
| 关闭 |
|
|
|
